Country: United States
Language: English
Source: NLM (National Library of Medicine)
POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152)
Par Pharmaceutical, Inc.
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 8 meq
ORAL
PRESCRIPTION DRUG
BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. - 1.For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - 2.For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and certain diarrhe
Potassium Chloride Extended-Release Capsules, USP, 8 mEq (600 mg) in a hard gelatin capsule with white opaque cap imprinted with “par” and white opaque body imprinted with “C219” in black ink containing white to off white spherical shaped coated pellets. Bottles of 100 (NDC 10370-219-01) Bottles of 500 (NDC 10370-219-05) Potassium Chloride Extended-Release Capsules, USP, 10 mEq (750 mg) in a hard gelatin capsule with dark blue opaque cap imprinted with “par” and dark blue opaque body imprinted with “C220” in black ink containing white to off white spherical coated pellets. Bottles of 100 (NDC 10370-220-01) Bottles of 500 (NDC 10370-220-05) Potassium chloride extended-release capsules are store at controlled room temperature, 20º to 25ºC (68º to 77ºF). [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP. Manufactured by: Par Pharmaceutical Companies, Inc. Spring Valley, NY 10977 I04/13
Abbreviated New Drug Application
POTASSIUM CHLORIDE EXTENDED-RELEASE- POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE PAR PHARMACEUTICAL, INC. ---------- POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES, USP 8 MEQ AND 10 MEQ R Only DESCRIPTION Potassium Chloride Extended-Release Capsules, USP, are 8 mEq and 10 mEq are oral dosage forms of microencapsulated potassium chloride containing 600 and 750 mg, respectively, of potassium chloride, USP, equivalent to 8 and 10 mEq of potassium. Dispersibility of potassium chloride (KCl) is accomplished by microencapsulation and a dispersing agent. The resultant flow characteristics of the KCl microcapsules and the controlled release of K+ ions by the microcapsular membrane are intended to avoid the possibility that excessive amounts of KCl can be localized at any point on the mucosa of the gastrointestinal tract. Each crystal of KCl is microencapsulated by a process with an insoluble polymeric coating which functions as a semi-permeable membrane; it allows for the controlled release of potassium and chloride ions over an eight- to ten-hour period. Fluids pass through the membrane and gradually dissolve the potassium chloride within the micro-capsules. The resulting potassium chloride solution slowly diffuses outward through the membrane. Potassium chloride extended-release capsules are electrolyte replenishers. The chemical name of the active ingredient is potassium chloride and the structural formula is KCl. Potassium chloride, occurs as a white, granular powder or as colorless crystals. It is odorless and has a saline taste. Its solutions are neutral to litmus. It is freely soluble in water and insoluble in alcohol. The inactive ingredients are, ethylcellulose, gelatin, sodium lauryl sulfate, FD&C Blue #1, FD&C Red #40, titanium oxide, triacetin, shellac, iron oxide black, isopropyl alcohol, n-butyl alcohol, propylene glycol, ammonium hydroxide, FD&C Blue #2, FD&C Red #40, FD&C Blue #1 and D&C Yellow #10. CLINICAL PHARMACOLOGY Potassium ion is the principal intracellular cation of most body tissues. Potassium io Read the complete document